ALLYSON BLOOM: Open Payments
NPI 1558030445 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 108 payments from 19 companies in 2025. Trend: 2023 $1,752 · 2024 $2,430 · 2025 $1,883
Food & beverage: $1,724Education: $159
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $304 |
| Novo Nordisk Inc | 17 | $281 |
| Amgen Inc. | 15 | $174 |
| Inspire Medical Systems, Inc. | 9 | $166 |
| ABBVIE INC. | 16 | $149 |
| PFIZER INC. | 8 | $143 |
| Janssen Pharmaceuticals, Inc | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| SANOFI-AVENTIS U.S. LLC | 4 | $86 |
| Lundbeck LLC | 3 | $73 |
Products named: REXULTI, INSPIRE, Wegovy, Veozah, SPRAVATO, NURTEC ODT, TZIELD, Ozempic.
Industry payments across GA — which companies pay providers there.
